Pharmaceutical Roundtable

In 2005, the ACS Green Chemistry Institute® and global pharmaceutical corporations developed the ACS GCI Pharmaceutical Roundtable to encourage innovation while catalyzing the integration of green chemistry and green engineering in the pharmaceutical industry. The activities of the Roundtable reflect its member's shared belief that the pursuit of green chemistry and engineering is imperative for business and environmental sustainability.

Recent News & Highlights:


Chem21 Learning Platform
An excellent resource for medicinal and process chemists who are interested in learning ‘greening’ the synthesis of active pharmaceutical ingredients.

  • Mission & Strategic Priorities

    Mission

    ACS GCIPR's mission is to catalyze the implementation of green chemistry and green engineering in the global pharmaceutical industry.

    Strategic Priorities

    Inform and Influence the Research Agenda

    • To monitor and identify new research opportunities with implications for more efficient process development and production.
    • To influence the technical agendas of federal/international funding agencies by defining needs and advocating investment in specific areas of green chemistry and engineering innovation.
    • To encourage external funding support for research in academic and government laboratories that will have direct value to the pharmaceutical industry.

    Tools for Innovation

    • To identify, design, and provide tools available to member companies to promote green chemistry and engineering innovation within the industry. To provide a centralized resource for accumulating alternatives, sharing tools, maintaining the toolbox, and minimizing duplication of effort.

    Educational Resource

    • To educate and influence today's and tomorrow's pharmaceutical leaders on the business value and scientific merit of green chemistry and engineering and its application in the pharmaceutical industry.

    Global Collaboration

    • To provide green chemistry and engineering expertise to pharmaceutical corporations worldwide by utilizing the ACS GCI network of international affiliates and researchers and by sharing best practices among our members.
  • Membership

    Member companies who are part of the ACS GCI Pharmaceutical Roundtable come together to catalyze innovative approaches to improving process efficiency and product quality through green chemistry and engineering. By working together, the Roundtable provides leadership and influence throughout the industry and supply chain. For example, the Pharmaceutical Roundtable has awarded over $1.99 million dollars in funding to further key research priorities for greener chemistries. In addition, the Roundtable continues to develop a valuable set of tools including a solvent selection guide, Process Mass Intensity/LCA calculator, and a powerful reagent guide. 

    The ACS GCI Pharmaceutical Roundtable invites all corporations meeting the definition of membership to consider joining. Companies are encouraged to join if they are committed to the integration of green chemistry and green engineering into the business of drug discovery and production.

    The ACS GCI Pharmaceutical Roundtable welcomes the active participation of companies meeting the following eligibility descriptions:

    Membership Eligibility

    Any corporation, or subsidiary, division or unit thereof, significantly engaged in the manufacture and marketing of finished dosage form ethical pharmaceutical or biological products under his or its own brand names for the cure, alleviation, mitigation, treatment, prevention or diagnosis of disease, and significantly engaged in pharmaceutical, biopharmaceutical or biological research and development of new molecular entities or new therapies, preventative, or in vivo diagnostics, or new systems of therapy, prevention, or diagnosis and who will continue to conduct such research and development.

    Associate Membership Eligibility

    Associates shall be corporations, or subsidiaries, divisions or units thereof, not eligible for membership under Members above, who are:

    1. Significantly engaged in research and development on their own behalf or as a provider of contract research and development services to companies meeting the definition of Member, directly related to the development or production of ethical pharmaceutical or biological products for the cure, alleviation, mitigation, treatment or prevention of disease.
    2. Significantly engaged in the manufacture of intermediates, active pharmaceutical ingredient, or finished dosage form ethical pharmaceutical or biological products.

    Associates shall have all the rights, privileges and duties prescribed by the Business Plan, and such other rights, privileges and duties as the Management Team may from time to time establish by resolution, except the right to vote.

    Membership Fees

    Membership fees are restricted for the purpose of meeting the project needs of the Roundtable. Annual fees range from $10,000 to $25,000 depending on company sales.

  • Grants

    The Roundtable issues Request for Proposals for grants on a regular basis. At this time, there are no open RFPs. 

    See Previously Awarded ACS GCI Pharmaceutical Roundtable Grants

    Read a review of the Roundtable's grant program:

    Evaluating the Impact of a Decade of Funding from the Green Chemistry Institute Pharmaceutical Roundtable
    Stefan G. Koenig, David K. Leahy, and Andrew S. Wells
    Organic Process Research & Development Just Accepted Manuscript
    DOI: 10.1021/acs.oprd.8b00237

  • Tools

    The ACS GCI Pharmaceutical Roundtable is dedicated to developing high quality green chemistry tools for Roundtable members as well as the public.

    Publicly Accessible Tools

    Member Only Tools

    • Process Mass Intensity - Life Cycle Analysis (PMI-LCA) Tool
    • Spotfire Interactive Solvent Selection Guide
    • New Reagent Guides
    • PMI Prediction Tool

    For more information, see the Green Chemistry Tools page

  • Publications

    The ACS GCI Pharmaceutical Roundtable is a frequent and influential publisher. For example, "Key green chemistry research areas—a perspective from pharmaceutical manufacturers" published in Green Chemistry in 2007 has received over 283 citations. The Roundtable's most recent papers and presentations are:

    For a complete list, see Publications.

  • Press

  • Meetings & Events

    Roundtable Meetings

    The ACS GCI Pharmaceutical Roundtable meets on a regular basis to advance their agenda. Meetings are member-only, but perspective members may inquire about attending by emailing gcipr@acs.org.

    Upcoming:

    ACS GCIPR Meeting
    Ipsen, Ireland | March 2018

    Past Meetings & Events:

    Select recent meetings and events include:

    ACS GCIPR Meeting
    Piizer, Groton, CT | October 2018

    Recent Innovations in Flow Chemistry and Continuous Manufacturing
    Pfizer, Groton, CT | October 11, 2018

    Green Chemistry in the Pharmaceutical Industry
    University of Stanford, CA | October 3, 2018

    22nd Annual Green Chemistry & Engineering Conference
    Portland, Oregon | June 18-20, 2018

    Green Chemistry in the Pharmaceutical Industry
    MIT, Cambridge, MA | May 5, 2018

    ACS GCIPR Meeting
    GSK, Stevenage, U.K. | March 2018

    ACS GCIPR Meeting
    Boehringer Ingelheim, Ingelheim am Rhein, Germany | October, 2017

    ACS GCIPR Workshop
    Solvent & Reagent Selection Tools & Techniques To Drive Green & Sustainable Chemistry
    Mumbai, India | October 6, 2017

    ACS GCIPR Meeting
    Reston, Virginia | June, 2017

    ACS GCIPR Meeting
    Genentech, South San Fransisco, California | April, 2017

    ACS GCIPR Symposia 
    Innovating for a More Sustainable Pharmaceutical Industry
    Novartis Institutes for BioMedical Research, Cambridge, Mass. | October 13, 2016

    ACS GCIPR Meeting
    Novartis Institutes for BioMedical Research, Cambridge, Mass. | October 11-12, 2016


Current Members

Abbvie amgen Astra Zeneca Bayer Biogen boehringerBristol-Myers SquibbhikalLilly Roche Gilead GSK Ipsen Johnson and Johnson Merck Neurocrinenova nordisk Novartis Pfizer Sanofi Takedavertex


Associate Members

Asymchem Codexis PharmaronWuxi AppTec

Download the GCI Pharmaceutical Roundtable Fact Sheet

Download the GCI Pharmaceutical
Roundtable Fact Sheet

Call for Abstracts Opens Soon

Take part in the 23rd Annual Green Chemistry & Engineering Conference and 9th International Conference on Green Chemistry held June 11-13, 2019 in Reston, Virginia.

Abstract Submission opens November 19th